Related Experiment Video
Updated: Mar 8, 2026
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.5K
Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas
Seiko Hirono1, Manabu Kawai1, Ken-Ichi Okada1
1Second Department of Surgery, School of Medicine, Wakayama Medical University, Wakayama, Japan.
JAMA Surgery
|January 26, 2017
Summary
Mural nodule size and pancreatic juice CEA levels help predict invasive intraductal papillary mucinous carcinoma (IPMC). These factors, along with patient demographics, improve invasive IPMC detection accuracy.
Area of Science:
- Gastroenterology and Hepatology
- Surgical Oncology
- Pathology
Background:
- Invasive intraductal papillary mucinous carcinoma (IPMC) exhibits aggressive behavior and lymph node metastasis.
- Identifying factors predicting IPMC is crucial for surgical planning, but these remain unclear.
Purpose of the Study:
- To identify specific factors associated with invasive IPMC in branch duct, main duct, and mixed types.
- To compare clinical features between invasive and noninvasive IPMN.
Main Methods:
- Retrospective cohort study of 286 patients with intraductal papillary mucinous neoplasm (IPMN).
- Comparison of clinical features between 96 invasive IPMC and 190 noninvasive IPMN cases.
- Measurement of mural nodule size and pancreatic juice carcinoembryonic antigen (CEA) levels.
Main Results:
- High mural nodule size was independently associated with invasive IPMC across all types (P ≤ .04).
- Elevated pancreatic juice CEA levels were associated with mixed and main duct invasive IPMC (P ≤ .048).
- A combination of 4 factors achieved 86.0% accuracy in differentiating invasive from noninvasive IPMN, outperforming current guidelines.
Conclusions:
- Mural nodule size and pancreatic juice CEA levels are important predictors of invasive IPMC.
- Further large-scale studies are necessary to validate these predictive factors.
